Aatmaj Healthcare
- Market cap
- ₹ 53 Cr.
- P/E
- 73.1x
- P/B
- 0.98x
- 52-week range
- 16.7 – 25.5
- ROE
- 1%
- ROCE
- 3.6%
- Dividend yield
- 0%
- Debt / equity
- 0.41
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- NSE SME
About
Aatmaj Healthcare Limited is an India-based company, which provides comprehensive hospital services. The Company’s principal activities include the operation of multidisciplinary private hospitals and clinics. The Company has units, namely Jupiter Hospital and group of JTP Hospitals. Its services and facilities include Invasive, Neurology, Neurosurgery, Nephrology, anesthesiology, orthopedics, neonatology services, ultrasound, dermatology, radiology, surgery, critical care medicine, 3D-4D sonography, urology care, modular operation theatres, joint replacement unit, echocardiography, pathology laboratory, and digital X-ray. It owns hospitals such as Jambusar General Hospital and JTP Sardar Patel with bed capacity of approximately 150 beds. It is associated with companies, organizations, universities and institutes providing regular healthcare check-up facilities for their employees and their post-graduation students.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →Aatmaj Healthcare against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)73.1 against a typical 48.9: pricier than most peers (1st = cheapest).26th of 40
- Sales growth+88.4% against a typical +21.1% from a year earlier.5th of 34
- Share price, 3 months+28.6% against a typical −10.9%.4th of 34
- Size₹ 53.1 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).31st of 36
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 29 Oct 2026Upcoming | Board Meeting Intimation | AATMAJ HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . |
| 14 May 2026 | Board Meeting Intimation | AATMAJ HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 14-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 . |
| 13 Nov 2025 | Board Meeting Intimation | AATMAJ HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2025 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2025 and Other business. |
| 27 May 2025 | Board Meeting Intimation | AATMAJ HEALTHCARE LIMITED has informed the Exchange about Board Meeting to be held on 27-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Other business. |
| 12 Nov 2024 | Financial Results/Other business matters | To consider and approve the unaudited financial results for the period ended September 30, 2024 and other business matters |
| 25 May 2024 | Financial Results/Dividend/Other business matters | To consider and approve the Standalone Audited Financial Results for the half year and year ended March 31, 2024, declaration of dividend, if any and other business matters. |
| 8 Nov 2023 | Financial Results/Other business matters | To consider and approve the unaudited financial results for the half year ended September 30, 2023 and other business matters |
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 13 | 14 | 9 | 7 | 9 | 11 | 11 | 14 |
| Expenses | 9 | 8 | 5 | 8 | 8 | 10 | 9 | 12 |
| Operating Profit | 5 | 5 | 4 | −1 | 0 | 1 | 1 | 1 |
| OPM % | 34.1% | 38.2% | 45.2% | −18.4% | 4.8% | 10.3% | 12.3% | 7.6% |
| Other Income | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 |
| Interest | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Profit before tax | 4 | 4 | 3 | −2 | 0 | 1 | 1 | 0 |
| Tax % | 27.6% | 29.3% | 27.4% | −22.2% | 6.1% | 55.4% | 26.1% | 28.6% |
| Net Profit | 3 | 3 | 2 | −1 | 0 | 0 | 1 | 0 |
| EPS in Rs | 5.37 | 1.86 | 1.01 | −0.62 | 0.14 | 0.15 | 0.23 | 0.09 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 8%
- 3 Years
- −2%
- TTM
- 18%
- 10 Years
- —
- 5 Years
- −29%
- 3 Years
- −50%
- TTM
- 13%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- −23%
- TTM
- —
- 10 Years
- —
- 5 Years
- 9%
- 3 Years
- 2%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Aatmaj Healthcare | ₹ 23.80 | ₹ 53 Cr. | 73.1x | 1x | 1% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 63x | 13x | 22% | 7.8% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 66.1x | 9.1x | 14.3% | 17.2% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 103.6x | 9.4x | — | 7.4% |
| Global Health | ₹ 1,165.00 | ₹ 31,449 Cr. | 67.4x | 9.5x | — | 11.8% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 64.2x | 6.9x | — | 11.3% |
Management
- Pratik Gandhi
- Chief Financial Officer
- Radhika Hissaria
- Compliance Officer, Company Secretary
- Tushar Karshanbhai Suvagiya
- Managing Director
- Jignasa Tusharbhai Suvagiya
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.